G2153

G2153 — In hospice or using hospice services during the measurement period

HCPCSTerminatedBETOS Z2

G2153 is a HCPCS Level II code for in hospice or using hospice services during the measurement period. It belongs to the Procedures and Professional Services (Temporary) section. It was terminated on December 31, 2020 and is not valid on new claims.

This code has been terminated

CMS terminated G2153 on December 31, 2020. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

The CMS record for G2153

Long descriptor: In hospice or using hospice services during the measurement period
Short descriptor: Hosp dur meas pd
Added: January 1, 2020
Terminated: December 31, 2020
BETOS: Z2
Pricing indicator: 00 — Not priced by Part B

Codes adjacent to G2153

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If G2153 is not quite right, the correct code is very often within a few positions of it.

G2145Functional status measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of less than 30 points
G2146Leg pain as measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 5.0 points or greater
G2147Leg pain measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated improvement of less than 5.0 points
G2148Multimodal pain management was used
G2149Documentation of medical reason(s) for not using multimodal pain management (e.g., allergy to multiple classes of analgesics, intubated patient, hepatic failure, patient reports no pain during pacu stay, other medical reason(s))
G2150Multimodal pain management was not used
G2151Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
G2152Residual score for the neck impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)
G2154Patient received at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement periodterminated
G2155Patient had history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)terminated
G2156Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period; or have history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)terminated
G2157Patients received both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during the measurement periodterminated
G2158Patient had prior pneumococcal vaccine adverse reaction any time during or before the measurement periodterminated
G2159Patient did not receive both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during measurement period; or have prior pneumococcal vaccine adverse reaction any time during or before the measurement periodterminated
G2160Patient received at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement periodterminated
G2161Patient had prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement periodterminated

Questions about G2153

What is HCPCS code G2153?

G2153 is a HCPCS Level II code for in hospice or using hospice services during the measurement period. It sits in the Procedures and Professional Services (Temporary) section.

Does Medicare cover G2153?

The CMS HCPCS file marks G2153 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

Is G2153 still valid?

No. G2153 was terminated on December 31, 2020 and should not be used on new claims.